MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso)
NCT 06097728 Brief Summary This is a phase III, randomized, open-label, multicenter,…
Read more arrow_forwardNCT 06097728 Brief Summary This is a phase III, randomized, open-label, multicenter,…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardACTRN 12623000959673 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 04106492 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12621001537842 Brief Summary This trial aims to determine whether NOX66 (idronoxil)…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forward